Evgen Pharma PLC (LSE:EVG) - Share price - Overview


Stock Report

Evgen Pharma PLC EVG

Last Price
GBX20.50

Day Change
0.00|0.00%

As of 26/03/2019
16:11:32 GMT | GBX
Minimum 15 Minutes Delay.

Last Close20.50p
Day Range18.10 - 21.00
Mkt Cap20.29Mil
52-Wk Range12.50 - 33.00
Yield %-
ISINGB00BSVYN304
Volume385,154
P/E-6.25
P/S-
P/CF-0.07

Share Price

Total Returns 25/03/2019

 Chg (%)  
More ...
Evgen Pharma PLC30.16 
FTSE 100 TR GBP0.44
 
Financials
201620172018
More ...
Income Statement
Turnover---
Operating Profit-2.03-3.66-3.03
Net Profit-3.13-3.07-2.58
Reported EPS-6.29-4.19-3.28
Balance Sheet
Current Assets7.324.604.14
Non Current Assets0.080.140.13
Total Assets7.404.744.26
Current Liabilities0.310.510.39
Total Liabilities---
Total Equity7.094.233.87
Cash Flow
Operating Cash Flow-1.56-3.22-3.01
Net Change in Cash4.96-1.26-0.23

Regulatory News

Company Profile

Evgen Pharma PLC is a clinical stage drug development company focused on cancer and neurological disease. Its pipeline is based on Sulforadex technology which includes synthetic and stabilized analogues of sulforaphane.

Sector

Drug Manufacturers - Specialty & Generic

Index

FTSE AIM All-Share

Next Event 13/06/2019

Final Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-78.17
Op Mrgn0.00
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorDr. Susan Elizabeth Foden
Executive Director, Chief Executive OfficerDr. Stephen Joseph Franklin
Executive Director, Chief Financial OfficerRichard Anthony Moulson BSc,FCA
Executive Director, ChairmanBarry Clare
Non-Executive DirectorDr. Alan John Barge
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.